header logo image


Page 556«..1020..555556557558..570580..»

World Hypertension Day 2020: Know the remedies for defeating this silent killer – Jagran English

May 17th, 2020 3:41 am

New Delhi | Jagran Lifestyle Desk: World Hypertension Day is observed on May 17 every year to increase the awareness about this ilent killer and help people realise that Hypertension or high blood pressure is a preventable and controllable condition.

Increasing the awareness about the condition -- where the blood pressure is consistently more than 140/90mm/Hg -- is necessary given the lack of knowledge among the people about the 'silent killer' as the symptoms often go unnoticed during the early phase.

Dr P Venkata Krishnan, Internal Medicine, at Paras Hospital, Gurugram, as quoted by news agency ANI, explains that the condition can be considered as the cause of many NCDs -- heart attacks, kidney failure, stroke, and also damage to eyes.

"Its prevalence is widespread with different studies concluding anywhere between one third and 50 per cent of the population suffering from hypertension. While 90 per cent of the cases of high BP is idiopathic, in 5 per cent of the cases, it is caused by underlying conditions of heart, thyroid and kidney diseases or other illness," said Dr Krishnan.

The major concern surrounding the condition is that of not showing any visible symptoms, and hence difficult to detect it via regular health and BP check-up. In fact, the doctor says that in most people, it is diagnosed during a regular check-up.

"Treating hypertension requires a combination of dietary and lifestyle modifications as well as medicines under medical supervision. Taking proactive steps such as a decrease in the consumption of junk food, managing stress, and regular exercise are important not just in the management of hypertension but also its prevention," he concluded.

Highlighting another viewpoint around the condition, Dr Parul Katiyar, Fertility Consultant, Nova IVF Fertility, said that hypertension can also adversely affect fertility, especially in men.

"Various studies have suggested that hypertensive men tend to have low semen volume, sperm count and motility. Some of the antihypertensive medications have been linked to poor semen volume and quality and their side-effects also include retrograde ejaculation and erectile dysfunction," remarked Dr Katiyar.

The doctor also emphasised that hypertension can be managed by bringing certain changes in the lifestyle and also intake of the right medication can result in improvement in impaired semen and erectile dysfunction.

Talking about chronic hypertension during pregnancy, Dr Manisha Ranjan, Consultant Obstetrician and Gynaecologist, Motherhood Hospital, Noida, said that the condition has been associated with a number of adverse pregnancy outcomes, including premature delivery, fetal growth restriction, fetal death, placental abruption, and cesarean delivery.

"Sometimes, the onset of high blood pressure during pregnancy may be a sign of preeclampsia, a condition in which high blood pressure occurs exclusively in pregnancy. Therefore, even if your chronic high blood pressure is under control before you are pregnant, you may later develop preeclampsia, as well," she added.

The doctor further recommended inducing labour before the patient's due date in order to prevent any pregnancy complications. In some cases, cesarean birth is also recommended.

"So, it becomes imperative that one should manage their high blood pressure during pregnancy by eating a healthy diet, reducing sodium intake, taking medications properly, and staying physically active," the gynaecologist explained.

Referring to the prevailing coronavirus crisis, Dr Manjeetha Nath Das, Internal Medicine, Columbia Asia Hospital, said that the condition has emerged as serious comorbidity, especially for the elderly.

"Every third Indian grown up has this disease. Its high prevalence makes all these people vulnerable to coronavirus, which may affect them more severely than those who are not hypertensive and increase the chances of death," said Dr Das.

"Therefore, our aim should be to check the number of new people who get hypertensive and help the hypertensive to manage their condition better. The disease also increases the risk of heart attack, stroke, kidney failure, and blindness significantly," the doctor said.

Dr Das further recommended proper screening of hypertension for anyone over the age of 35 years. "Besides, right from childhood, people should be encouraged to live a healthy and active lifestyle with less sugar and fat intake and minimum 30-minute of activity daily," Dr Das added.

(With ANI Inputs)

Posted By: Talib Khan

Here is the original post:
World Hypertension Day 2020: Know the remedies for defeating this silent killer - Jagran English

Read More...

IAN MANN REVIEWS | Getting the jump on problems before they happen – Fin24

May 17th, 2020 3:41 am

Upstream: The quest to solve problemsbefore they happen, by DanHeath

Picnicking beside a river, you see a child floatingdown, in danger of drowning. You and your friend dive in and save her, only tosee another coming down, and another and another. Suddenly you see your friendclimb out the river and start running. "Where are you going?"

"I am going to sort out the person who isthrowing children in the river!"

Author Dan Heath uses the word upstream forefforts intended to prevent problems before they happen.

"So why do our efforts skew so heavily towardreaction rather than prevention?" he asks. Primarily, because the furtherupstream we go back, the more complex the solution. It is easier to call HR torecruit a new executive than it is to ensure that the organisation is a deeplysatisfying place to work.

The US will spend billions more recovering from thecoronavirus because they slashed funding for Centers of Disease Control and Prevention.And similar examples abound.

"My goal in this book is to convince you thatwe should shift more of our energies upstream," Heath explains.

There are three forces that push us downstream,impeding our ability to prevent problems.

The first is what Heath calls problem blindness,the response to problems that is similar to the way we treat the weather there is nothing we can do about it.

The second is that no one takes ownership of theproblem. Stanford researchers, in a paper exploring this sense of reluctance,wrote "what often prevents people from protesting is not a lack ofmotivation to protest, but rather their feeling that they lack the legitimacyto do so."

The third is tunnelling, where people react toproblems rather than prevent them. Tunnelling confines us to short-term,reactive thinking. In the tunnel, theres only forward. When people experiencescarcityof money or time or mental bandwidththe harm is not that the bigproblems crowd out the little ones. The harm is that the little ones crowd outthe big ones.

If upstream thinking is so obviously correct andunequivocally more effective in eliminating recurring problems, why is it sorare? Heath identifies seven significant barriers to upstream thinking andprovides solutions from lessons learned from real world successes.

Heaths three forces described above, and the sevenbarriers (of which I will describe some below) are the same whether you lead afor-profit-business, a public benefit organisation or a government department.

How will you unite all theright people who are needed to solve the problem?

In 1998, 42% of Icelandic 15- and 16-year-olds hadbeen drunk in the previous 30 days. Almost a quarter smoked cigarettes daily,and 17% had already tried cannabis. Among 22 European countries, Icelandic teenagershad the second-highest rate of accidents or injuries related to substance abuse.Todays Icelandic teenagers have grown up in a country where substance abuse islargely absent.

As in many upstream efforts, the success wasachieved by surrounding the problem, recruiting a multifaceted group ofpeople and organisations, united by a common aim "Drug-free Iceland".

The campaign team solicited help from anyone whowas willing to assist: researchers, policymakers, schools, police, parents,teenagers, singers/musicians, government agencies, private companies, churches,sports clubs, athletes, and media members.

Surrounding the problem with the right people and aligningtheir efforts toward preventing specific instances of that problem, was theirsolution.

Who would need to be involved in your organisation?

How will you change the system?

"Every system is perfectly designed to get theresults it gets."

Whether the results are good or bad, the systemthrough which the results are achieved is a complete success.

In 1967, 5 people died for every 100 million milesdriven. Fifty years later, fewer drunk drivers better roads, seat belts,airbags and better braking technologies, reduced that number to 1 death per 100million miles driven. The vastly improved system happened with no centralplanner. Thousands of people, safety experts, transportation engineers andMothers Against Drunk Driving, tweaked the system so that millions of people aresafer.

Identifying the systems that need to change is criticallyimportant.

How will you get early warning ofthe problem?

When everything is cause for alarm, nothing iscause for alarm.

The value of an early warning depends on whetherthe warning gives sufficient time to respond. A car tyre that gives a 30-secondadvance warning of a blowout, might save your life. A half-second warning isworthless.

LinkedIn discovered that the churn rate forcustomers of their flagship product for recruiters was roughly 30%. On further investigationthey found that customers who used the product in the first 30 days were fourtimes more likely to continue using LinkedIn. So, they started using all theresources they had been using to save customers, to onboard them properly sothey become users immediately.

How will you know youresucceeding?

What counts as success? If my laptop broke and youfix it, thats victory. With upstream efforts, success is not alwaysself-evident and is often misleading.

Consider a team that applauds itself for scoringmore runs. Is that because every team in the league is scoring more too,because bowling talent has declined? The team that doubled its run rate barelywon any more games, which doesnt align with their goal.

If the short measures runs starts becoming the goal,players under pressure may start cheating. Here, succeeding with the measuremakes a mockery of the goal. Care must be taken which factors really measuresuccess.

How will you avoid doing harm?

Systems are complicated. One need only consider theban of single use plastic bags that damage the waterways.

An estimated 100 billion bags that may not degradefor hundreds of years, are used annually just in the US. Paper bags andreusable bags are far better than plastic ones from the perspective of keepingwaterways clean, but they are worse in other ways.

A UK Environment Agency study calculated the "peruse" effects of different bags on climate change. You need to use a paperbag 3 times and a cotton reusable bag 131 times to be on par with plastic bagsoverall effect on the environment. Manufacturing paper bags and cotton reusablebags causes more air and water pollution than plastic, and they are much harderto recycle.

Is protecting waterways and marine life our goal,or making the whole environment better?

Systems cant be controlled, but they can bedesigned and redesigned. We need to rely on careful experimentation, guided byfeedback loops. We should think very carefully before proceeding where systemsare involved. Upstream work hinges on an attitude of care and humility.

Who will pay for what does nothappen?

A person will pay if they will reap the rewards andwhat comes out of the pocket goes back in. But what if many units in the organisationor country will benefit, unequally? Getting funding for many pockets is acoordination nightmare.

In the case of climate control, those who areresponsible for the problem (wealthy countries,) require a contribution in cashor kind from poor countries who benefit from the solution, but did little tocause the problem.

Not considering these questions will make upstreamsuccess ever harder. Considering them may go a long way to improve youroperations and I cannot think of any time when that consideration is morenecessary.

I consider this the most useful book I have read inyears. It reads easily and is rich with examples and nuances.

Readability Light--+-- Serious

Insights High +---- Low

Practical High -+--- Low

*Ian Mann of Gateways consultsinternationally on strategy and implementation, is the author of Strategy thatWorks and a public speaker. Views expressed are his own.

See the original post:
IAN MANN REVIEWS | Getting the jump on problems before they happen - Fin24

Read More...

Reach Ramadan Challenge: how you can raise money for river blindness on TikTok – The National

May 15th, 2020 7:46 pm

You can now do your bit for charity this Ramadan by creating a video on social networking platform TikTok.

The video-sharing service has joined the Reach Campaign, an Emirates Red Crescent-organised drive that targets neglected tropical diseases, as its latest media partner. TikTok has pledged to donate $2 (Dh7) for every video created on the app, up to a maximum of $100,000.

The Reach Campaign launched in January and uses the theme Give 2, Save 2 meaning that a Dh2 donation is enough to provide medicine and treatment to protect one person against both diseases for an entire year.

During Ramadan, however, the campaign set a goal of protecting one million people from river blindness over the course of the holy month.

TikTok users can contribute by creating videos using three special interactive "Reach Campaign stickers", or donating directly to the cause through links on the campaigns in-app landing page.

TikTok will also run in-app advertisements shedding light on river blindness, and has encouraged several high-profile public figures to take part in the challenge.

Social media influencers Max of Arabia, Khalid and Salama Al Ameri, Abas, and Mona Sheikh have so far created #ReachTheEnd videos.

More than 200 million people worldwide require treatment for river blindness, one of the leading causes of preventable blindness. It is caused by repeated bites by black flies that live near flowing water.

Like many neglected tropical diseases, river blindness disproportionately affects the worlds most vulnerable people, trapping their families in cycles of poverty. Most of the cases are found in 31 countries in sub-Saharan Africa.

"We are excited to launch a new element to the campaign in collaboration with an innovative partner such as TikTok. Allowing the community to participate creatively while helping reach the end of river blindness has truly inspired users to join our campaign.

"We are honoured to see the inventive ways people continue to show their support from the comfort of their own homes," Nassar Abdul Raouf Al Mubarak, managing director of the Reach Campaign said.

In addition to TikTok videos, the month-long Reach Ramadan campaign follows a simple three-step challenge: the community is encouraged to donate by either texting GIVE to 2424, visiting the Reach the End website, or posting a selfie on social media making a "V for victory over river blindness" sign with their hands, and challenging friends and family to do the same by by tagging them.

Updated: May 12, 2020 05:15 PM

Originally posted here:
Reach Ramadan Challenge: how you can raise money for river blindness on TikTok - The National

Read More...

Intravitreal IVT Injectable Market Worth Will Reach US$ 4350 Mn According To Forecast By 2028 – Cole of Duty

May 15th, 2020 7:46 pm

Retinal diseases contributing heavily to the demand growth of intravitreal (IVT) injectables

Hereditary retinal diseases is the major cause of visual loss. Macular degeneration, Diabetic Retinopathy is the important and prominent cause of blindness.

According to Genentech Retinal disease report, around 11 million US population are affected with age-related macular degeneration, 7.7 million people are affected with diabetic retinopathy and around 1.1 million population are affected with retinal vein occlusions.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25906

Company Profiles

Anti-VEGF intravitreal (IVT) injectables medication is most likely use to treat retinal disorders. Increasing prescription of anti-VEGF anticipate the growth of the intravitreal (IVT) injectables market. Many manufacturers aims to develop drugs with anti-VEGF inhibitor, as a result leading to an increase in the demand for intravitreal (IVT) injectables.

North America to have substantial revenue growth in intravitreal (IVT) injectables Market

North America region shown to have high growth inintravitreal (IVT) injectables market. Low vision and blindness are prevailing in the region and high prescription of anti-VEGF intravitreal (IVT) injectables medication has increases the growth of intravitreal (IVT) injectables market. It is estimated that intravitreal (IVT) injectables create an incremental $ opportunity worth US$ 4,350 Mn between 2018 and 2028.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25906

Lucentis marketed by Roche and Eylea marketed by Regeneron in the United States, are the commonly prescribed biologics use in intravitreal (IVT) injectables. Apart from this, Avastin and Macugen are also widely used in intravitreal (IVT) injectables market.

The North America region holds a significant share in intravitreal (IVT) injectables among all other regions, due to the increase in prescription of retinal biologics, high healthcare facilities and availability and usage of expensive drugs.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/25906

Intravitreal (IVT) Injectables Market: Segmental Analysis

The global intravitreal (IVT) injectables market has been segmented on the basis of drug class, indication and distributional channel. On the basis of drug class, the intravitreal (IVT) injectables market has been segmented into anti-VEGF, corticosteroids, antibiotics, antivirals and antifungals. Based on indication, the intravitreal (IVT) injectables market has been segmented into diabetic retinopathy, macular degeneration, endophthalmitis, retinal vein occlusions and others.

In terms of revenue, the anti-VEGF segment is expected to have a major share in intravitreal (IVT) injectables during the forecast period as it prevents angiogenesis and also minimize the leakage of fluid that occurs due to retinal diseases.

On the basis of distributional channel, the intravitreal (IVT) injectables market has been categorized into hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies and others. The hospital pharmacies is expected to have high revenue growth in intravitreal (IVT) injectables, owing to the availability of biologics and increase in prescription of anti-VEGF drugs.

Report Highlights:

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Opioids MarketOpioids Market Segmented By Morphine, Codeine, Fentanyl, Meperidine, Methadone Product in Analgesia, Cough Suppression, Diarrhea Suppression.For More Information

Non Infectious Macular Edema Treatment MarketNon-infectious Macular Edema Treatment Market Segmented By Anti-VEGF, Corticosteroids, Immunosuppressant, Biologics Drug with Non-infectious Uveitic Macular Edema, Diabetic Macular Edema, Retinal Vein Occlusion with Macular Edema Indication by Oral, Parenteral, Topical Route of Administration.For More Information

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

See the original post here:
Intravitreal IVT Injectable Market Worth Will Reach US$ 4350 Mn According To Forecast By 2028 - Cole of Duty

Read More...

Educate Patients About the Basics of Blepharitis – Pharmacy Times

May 15th, 2020 7:46 pm

Yvette C. Terrie, BSPharm, RPh

The common ocular condition accounts for an expanding percentage of primary care medical visits.1 Although blepharitis does not typically result in blindness, left intreated, it has can cause corneal neovascularization and ulceration, keratopathy, and permanent alterations in eyelid morphology.2 The pathophysiology is thought to stem from a bacterial infection, dermatologic conditions such as rosacea and seborrheic dermatitis, or a problem with the oil glands near the base of the eyelids.3 Common clinical presentation includes burning and/or itching of the eyelid margins and/or conjunctival irritation with lacrimation, photosensitivity, or the sensation of a foreign body.2,3

Blepharitis is classified into 2 types, according to the American Optometric Association.2 Anterior blepharitis affects the outside front of the eyelid, where the eyelashes are attached. The 2 most common causes of anterior blepharitis are bacteria (Staphylococcus) and scalp dandruff.2 Posterior blepharitis affects the inner eyelid and is caused by problems with the oil (meibomian) glands in this area. Two dermatologic disorders can cause this form of blepharitis: acne rosacea, which leads to erythema, and seborrheic dermatitis.2

Self-treatable ophthalmic disorders primarily affect the eyelids, but it is important that patients always seek medical guidance to determine if an infection is present and rule out a more complicated condition or disorder.4 Pharmacists can assess if self-treatment is appropriate, direct patients to seek further medical care when warranted, and provide information about blepharitis. They can also educate patients about eyelid hygiene, including related nonprescription products, and the numerous OTC artificial tear products that may provide symptomatic relief.

PRACTICING PROPER EYELID HYGIENE Even with successful treatment, blepharitis may recur. Treatment depends on the severity and type of blepharitis, and some cases require more complex regimens. Blepharitis rarely disappears completely.5,6 Proper eyelid hygiene is the foundation of treatment and is effective in most cases.3

For a bacterial infection that does not respond to eyelid hygiene, a prescription topical antibiotic ointment may be warranted.5 A severe case may call for an oral antibiotic and a short course of a steroid.3,5 Because most blepharitis cases are chronic, patients need to follow a good hygiene regimen to prevent recurrence. Recommended measures include:2,3,5

PATIENT EDUCATION RESOURCES American Academy of Ophthalmology: aao.org/eye-health/diseases/ what-is-blepharitisMayo Clinic: mayoclinic.org/diseases-conditions/blepharitis/symptoms- causes/syc-20370141National Eye Institute: nei.nih.gov/learn-about-eye-health/eye-conditions- and-diseases/blepharitis

REFERENCES

Continued here:
Educate Patients About the Basics of Blepharitis - Pharmacy Times

Read More...

Retinitis Pigmentosa (RP) Market Poised to Expand at a Robust Pace Over 2025 – Cole of Duty

May 15th, 2020 7:46 pm

Retinitis pigmentosa, is a condition where patients typically loses ability to see at night in young years, side vision in middle age, and focal vision in later in his/her life due to relentless loss of cone photoreceptor cells. Proportions of retinal capacity, for example, the electroretinogram, demonstrate that photoreceptor capacity is decreased normally quite before symptomic night visual impairment, visual-field scotomas, or diminished visual sharpness emerge. Retinitis Pigmentosa (RP), an acquired retinal condition that causes retinal depletion, is an uncommon illness. Its underlying manifestations are decreased night vision along with loss of fringe vision. It slowly causes visual impairment.

Get Exclusive PDF Sample Copy Of This Report:https://www.tmrresearch.com/sample/sample?flag=B&rep_id=91

There is no conclusive remedy for retinitis pigmentosa. Hence medical institutions and various research and development centers are researching to develop a full proof cure for this disease which is boosting the growth of global retinitis pigmentosa market.

Retinitis pigmentosa, in which patients usually lose night vision in teenage years, side vision in middle age, and central vision in later life because of steady loss of cone photoreceptor cells and rod. Measures of retinal function, such as the electroretinogram, indicate that photoreceptor function is reduced usually several years before visual-field scotomas, symptomic night blindness, or reduced visual acuity arise.

As of now, there are no specific treatments available for retinitis pigmentosa. Efficient treatments for retinitis pigmentosa are much awaited, particularly for genetically defined subsets of patients. Various studies suggest that this disease affects about 1 in 4,000 individuals worldwide. Without treatment, patients permanently lose central vision by the age of 60. For past many years, there have been several treatments reported, which did not completely cure the disease but were beneficial to some extent. For instance, in the past, patients used to consume a supplement of 15,000 I.U. of Vitamin A and possibly fish oilto address this conditions. In 2011, a method of treatment was patented, in which a medical dose of insulin, IGF-1, and chlorin e6 was used. Another treatment option which was proposed in November 2012 was a combined treatment regimen ofoily fish (DHA), vitamin A palmitate, and lutein. This treatment was reported to slow vision loss in people suffering from the disease. Rare forms may also be treated with vitamin supplements or diet modification.

Looking at the immense growth potential, several new players are likely to venture into the global retinitis pigmentosa market, thereby making it a highly competitive arena in the near future.

Retinitis Pigmentosa (RP), an inherited retinal condition causing retinal degeneration and visual field loss, is a rare disease. Its initial symptoms are reduced nightvisionand loss of peripheral vision. It gradually causes blindness. There is no definitive cure for retinitis pigmentosa. Therefore, the market for treating this genetic disorder is vastly untapped. The available therapies apply various approaches such as stem cell therapy and transcorneal electric stimulation therapy. However, such therapies have not been approved of unanimously on account of certain intrinsic limitations.

A range of services and devices are available to aid people with vision loss to conduct their day to day activities independently. Those include anything from a vision aid and an eye care professional to orientation and mobility specialists and certified low vision therapists, among others.

The global retinitis pigmentosa market has been treading a healthy growth path due to limited availability of therapeutics to cure this rare disease which has opened up a window of opportunity for new therapies and treatments. In fact, most people afflicted with the genetic disorder progress to the advanced stage of retinitis pigmentosa because of the dearth of proper cure. This has generated demand for retinal prosthesis devices for restoring the lost vision. Second Sight Medical Products, Inc., for example, offers FDA approved Argus II retinal prosthesis system meant for patients with advanced retinitis pigmentosa. This device does the function of degenerated retinal cells and enhances the patients ability to see images and movement.

A new approach known as optogenetics, which involves applying gene therapy for restoring vision, is currently being researched upon by companies operating in the ophthalmology market. It helps to power cells, especially ganglion cells, to respond to light after the degeneration of rod cells and cone cells. Further, the orphan drug designation given by the FDA and European Commission to ReN003 by ReNeuron in the U.S. and Europe in 2013 is another positive development in the market. ReN003 is a retinalstem cell therapycandidate.

Buy This Report @https://www.tmrresearch.com/checkout?rep_id=91<ype=S

Based on geography, the global retinitis pigmentosa market can be segmented into North America, Europe, Asia Pacific, and the Rest of the World. Among them, North America and Europe dominate the market powered by the developed markets of the U.S and U.K. where exhaustive research and development activities have been carried out in this direction. However, the Asia Pacific retinitis pigmentosa market is also poised for growth due to the large patient pool in the region, who need to be treated for retinitis pigmentosa. The Rest of the World also has a substantial number of people suffering from this rare genetic disorder.

Companies Mentioned in Report

To present an study the current competitive dynamics in the global retinitis pigmentosa market, the report has profiled some of the major players involved in the development and commercialization of products in the field such as ReNeuron Group plc, Amarantus BioScience Holdings, Inc., Ocugen, Inc., ReGenX Biosciences, LLC, Sucampo Pharmaceuticals, Orphagen Pharmaceuticals, Inc., Inc., and Okuvision GmbH.

To know more about the table of contents, you can click @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=91

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in todays supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Continue reading here:
Retinitis Pigmentosa (RP) Market Poised to Expand at a Robust Pace Over 2025 - Cole of Duty

Read More...

The centre’s wilful blindness and control freakery hinders the Covid response – Local Government Chronicle

May 15th, 2020 7:46 pm

Councils face an uphill struggle when their budget shortfalls are not covered and local expertise is not trusted by ministers, writes LGC editor Nick Golding.

There has been criticism lately in certain quarters of journalists and commentators for their raising of deficiencies in the national coronavirus response. Questioning and scrutiny are seen as tantamount to treachery, working against the war effort and undermining ministers who face the unenviable task of having to take unprecedented action with imperfect information. Of course, this criticism is misplaced. It is the most fundamental job of the journalist to expose inefficiency, hypocrisy, mistruths and failure and far from being a fair-weather luxury this role becomes even more important during a crisis when such failings have an immediate detrimental effect on wellbeing and even survival.

LGC has been asking searching questions of the government, mainly around two key themes. First, do councils have the funding to protect their communities and, second, is local expertise being used to its full potential and sufficiently supported in an increasingly centralised operation? The answer to both questions from our readership has been an overwhelming no.

Councils have been regularly undermined by the centre

On finance, the mood music was initially positive. When ministers were telling councils to do whatever is necessary to support their place, the implication was their work would be fully funded. It seems communities secretary Robert Jenrick has lost a financial battle with the Treasury and his promise has been diluted to covering the costs of specific tasks councils have been told to do. Any expenditure on top of this will be merely taken into consideration while councils projections of sector-wide multi-billion pound income losses are deemed highly speculative. And it would, we were told, create a moral hazard to bail out authorities that had made unwise commercial investments, upon the success of which they are reliant. Mr Jenrick made no mention of the fact councils have done this the vast majority of them acting responsibly to try to recoup the funding they have lost at the hands of Conservative ministers.

To ignore councils dire straits amounts to delusional, head-in-sand, ostrich leadership. While the exact size of each councils shortfall for the rest of 2020-21 is uncertain, one thing is clear: unless far more funding than the current 3.2bn arrives, councils will collapse and local services will be decimated. Does Mr Jenrick really want that? Councils are having to take decisions now about expenditure for the rest of the year and need a clear commitment that their budget shortfalls will be covered. Mr Jenrick diluted his promises, condemning local service users to misery just as Boris Johnson was pledging no return to austerity, a meaningless statement unless backed by resources.

On the second theme, councils have been regularly undermined by the centre (despite the belated move which went live today for directors of public health to lead on care home testing). Councils have been bypassed on contact tracing, coordination of volunteers and sharing of data for the shielding service. The social care workforce has often been near the back of the queue for personal protective equipment while deaths in care homes were not even included in NHS England daily statistics for most of the crisis to date. And why have we not seen James Jamieson or Mark Lloyd, respectively the chair and chief executive of the Local Government Association, behind a lectern at the Downing Street briefing? They havent been invited because councils are not seen as a sufficiently important partner by the centre.

All of this undermines the effort to reduce the spread and impact of coronavirus. While aspects of the central response have been impressive, government incompetence, wilful blindness and control freakery are hindering councils efforts. Perhaps the greatest challenge now is rebuilding shattered local economies an operation that can only be successful if undertaken by empowered, properly funded local leaders. Every central action needs to be scrutinised, questioned and debated to ensure it aids the local response to coronavirus because at present too many are thwarting it. As Britains Covid-19 death rate soars higher than the rest of Europe there is a moral imperative to ask why? and can we as a nation do better?.

Original post:
The centre's wilful blindness and control freakery hinders the Covid response - Local Government Chronicle

Read More...

The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -…

May 15th, 2020 7:45 pm

DUBLIN--(BUSINESS WIRE)--The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

The cell-based markets was analyzed for 2018, and projected to 2028. The markets are analyzed according to therapeutic categories, technologies and geographical areas. The largest expansion will be in diseases of the central nervous system, cancer and cardiovascular disorders. Skin and soft tissue repair as well as diabetes mellitus will be other major markets.

The number of companies involved in cell therapy has increased remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 309 of these are profiled in part II of the report along with tabulation of 302 alliances. Of these companies, 170 are involved in stem cells.

Profiles of 72 academic institutions in the US involved in cell therapy are also included in part II along with their commercial collaborations. The text is supplemented with 67 Tables and 25 Figures. The bibliography contains 1,200 selected references, which are cited in the text.

This report contains information on the following:

The report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Role of cells in drug discovery is also described. Cell therapy is bound to become a part of medical practice.

Stem cells are discussed in detail in one chapter. Some light is thrown on the current controversy of embryonic sources of stem cells and comparison with adult sources. Other sources of stem cells such as the placenta, cord blood and fat removed by liposuction are also discussed. Stem cells can also be genetically modified prior to transplantation.

Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine. Pharmaceutical applications of stem cells including those in drug discovery are also described. Various types of cells used, methods of preparation and culture, encapsulation and genetic engineering of cells are discussed. Sources of cells, both human and animal (xenotransplantation) are discussed. Methods of delivery of cell therapy range from injections to surgical implantation using special devices.

Cell therapy has applications in a large number of disorders. The most important are diseases of the nervous system and cancer which are the topics for separate chapters. Other applications include cardiac disorders (myocardial infarction and heart failure), diabetes mellitus, diseases of bones and joints, genetic disorders, and wounds of the skin and soft tissues.

Regulatory and ethical issues involving cell therapy are important and are discussed. Current political debate on the use of stem cells from embryonic sources (hESCs) is also presented. Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.

Key Topics Covered

Part I: Technologies, Ethics & Regulations

Executive Summary

1. Introduction to Cell Therapy

2. Cell Therapy Technologies

3. Stem Cells

4. Clinical Applications of Cell Therapy

5. Cell Therapy for Cardiovascular Disorders

6. Cell Therapy for Cancer

7. Cell Therapy for Neurological Disorders

8. Ethical, Legal and Political Aspects of Cell therapy

9. Safety and Regulatory Aspects of Cell Therapy

Part II: Markets, Companies & Academic Institutions

10. Markets and Future Prospects for Cell Therapy

11. Companies Involved in Cell Therapy

12. Academic Institutions

13. References

For more information about this report visit https://www.researchandmarkets.com/r/7h12ne

Follow this link:
The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -...

Read More...

Medical School: Who gets in and why – Stuff.co.nz

May 15th, 2020 7:45 pm

Few would question the benefits of a medical profession which reflects the socio-demographic make-up of New Zealand. Our medical schools are now boosting Mori, Pasifika and rural student numbers but have they got the balance right? MARTIN VAN BEYNEN reports.

Harry* is a bright and social 18-year-old who was always passionate about becoming a doctor. He was brought up in a well-off home by professional parents but family issues meant life was no bed of roses.

He completed the first year health science course at the University of Otago last year with an A+ average grade and also managed a top score in the required University Clinical Aptitude Test (UCAT). He was absolutely gutted and so were his parents when he was not accepted into Otago Medical School.

Incredibly, his academic results were not good enough. His disappointment was not helped by students with far lower grades and poorer UCAT results being accepted under special categories including Mori and Pasifika, rural and low socioeconomic.

Harry, of European descent, was not alone in his disappointment. Other European and Asian students faced similar setbacks. At least one family has threatened legal action.

READ MORE:* She aspired to be a doctor at 10, to 'make a point' that Mori can * We need more diversity in our health system - entrance schemes help* Emails reveal Otago and Auckland's med school meddling * Auckland and Otago medical schools undermine Waikato bid* Record numbers of Maori doctors graduate from med school

Its a touchy subject. Few would disagree that elite professions like medicine should reflect the socio-demographic make-up of the general population. Evidence suggests that doctors who have more things in common with their patients will be more empathetic and have more success in diagnosis and getting patients to follow recommended treatments.

But have the medical schools gone too far in trying to redress the balance by squeezing out a growing number of general students? And have entry requirements become too easy to manipulate?

For a long time the medical school intake from some sections of society, notably Mori and Pasifika, was much lower than their proportion of the population.

Only a decade ago, a mere 7.6 per cent of new domestic medical students at Otago identified as Mori and 2.7 per cent as Pasifika. The ramifications show up in the current medical workforce in which only 3.4 per cent are Mori and 1.8 per cent Pasifika. Their respective proportions of the total population are about 15 per cent and 8 per cent.

However, a big change was seen after more robust affirmative action policies were implemented at medical schools after 2010. By 2016 Mori and Pasifika students entering Otago Medical School had increased by 179 per cent Mori were about 16 per cent of domestic students and Pasifika students counted for 5.6 per cent.

One group, however, showed little improvement. In 2010 only 2.4 per cent of Otago medical students had attended a secondary school with a socioeconomic decile of less than four.

By 2016, the percentage had grown to 4.7 per cent.

Wiremu*, now training to be a general practitioner, was one of those students who benefited from affirmative policies designed to increase Mori in the medical workforce. A product of kohanga reo and a low decile Mori immersion primary school, he had a flair for science and wanted to work with people.

His low decile high school had not prepared him well for the highly competitive intermediate year at Auckland University, but he worked his guts out and was accepted into its medical school.

His life experience in different sections of the community, including gang families, enables him to relate to patients better than a book-smart, nerdy type from a privileged background, he says.

As a junior doctor, he was often able to get through to certain Mori patients just by saying his name.

Supplied

Some people cant see the difference between equity and equality," says a junior doctor.

They suddenly realised there was a Mori person on the other side. You just have to see their face when I say Kia Ora Im Wiremu some of them go, True Bro I thought you were Pkeh. In certain circumstances we will have a chat in Mori and obviously that's useful. Then we have a brief introduction period, you get to know the other person. Pronouncing someones name correctly is massive.

He says getting more Mori into medical schools wont fix the inequities in health outcomes but it will help.

Some people cant see the difference between equity and equality. Ive learned so much about why Mori are the way we are today. Sometimes you have to direct more resources to some people for outcomes to be equal.

Some students manipulate the system, but they are a small minority, he says.

For this years intake, Otago had 202 places available for first year students entering from its intermediate year. (Otago does not take first year students from other universities).

Of those, 120 were given to those entering under a raft of categories.

Of those, 58 were Mori, 20 were Pasifika, 1 Mori/Pasifikaand 29 entered through the rural gate. Eleven students went in under the low socio-economic category and one under a new refugee category. That left only 82 general entry places (40 per cent).

As well as the 202 places for first year students, Otago medical school fills another 80 places with graduates. Overall for 2020, Mori and Pasifika make up 32 per cent of students starting at the school, while 14 per cent have rural backgrounds, 4 per centlow socioeconomic, and 1per cent refugee.

Auckland medical school shows a similar pattern. For the 2020 year it had 185 places for first year health science or bio-medicine students. Mori and Pasifika took up 52 places, rural got25, disabled 2, low socioeconomic 5 and refugee1. That left 101 places (55 per cent) for general entry students.

Looking at percentages for the 2020 intake, Mori and Pasifika students took up nearly 40 per cent of the places at Otago for first year health science students and 28.1 per cent of the total places for first year students at Auckland.

At Otago that meant general entry students had to get, as one student put it, ludicrously high grades to be accepted. In fact candidates needed at least a 94 per cent average mark for their seven papers to get an offer.

The father of a European student who missed out on this years intake at Otago despite stellar marks says he can understand why district health boards and central government want the medical workforce to be representative.

Where I have difficultyis reconciling that with students who would make wonderful doctors and have extremely high marks being lost to the medical profession.

The average mark for the sub-category entrants is not held by the university and it was not able to provide it before deadline.

However, sub-category entrants must get a 70 per cent minimum for each paper. Those who achieve an average of at least 70 per cent can be admitted with individual subject marks under 70 per cent so long as the admissions committee is satisfied about their academic ability to complete the programme.

At Otago, a candidates overall UCAT score does not count in the assessment by the admissions committee but general candidates must score in the top 80 per cent of results for verbal reasoning and in the top 90 per cent for situational judgement.

Suppled

This could hurt:Medicine does not need society's brightest students, says a top medical educator.

Critics say the low thresholds are farcical because no-one with good enough grades to be a doctor will go below the thresholds. The university says it uses the scores when choosing between candidates who are otherwise very similar.

The thresholds do not apply to Mori and Pasifika candidates. They are assessed by reference to specific material provided by applicants about their engagement with their communities.

In Auckland, admission is based on an interview (25 per cent), first year marks (60 per cent), and the UCAT result (15 per cent).

Otago University cannot say how many Mori and Pasifika students would have met the grades required by successful general applicants in this years intake, but Professor Paul Brunton, Pro-Vice-Chancellor, Health Sciences says if affirmative action had not been undertaken both Mori and Pasifika students would have been significantly under-represented in this years class compared with the make-up of New Zealand society.

Does the medical school have a cap on sub-category students?

Brunton says the Education Act states affirmative action places can only be offered where a relevant category of applicant would otherwise be under-represented in the medical programme.

To date, the number of sub-category students we have been able to admit continues to be well below the needs of the health workforce.

The Government funds 55 rural places at each of the universities of Otago and Auckland, he says.

Medical school applicants at Otago need to meet a number of requirements to be successful under the various subcategories.

The Mori and Pasifika category requires students to verify their ancestry by, for instance, an iwi registration document or, for Pasifika, a community leaders endorsement.

Applicants under the rural category can hail from places such as Helensville and Pukekohe near Auckland, Lincoln and Rangiora on the outskirts of Christchurch and Featherston, Greytown and Martinborough near Wellington. They also include Queenstown Bay, Frankton, Cromwell and Wnaka.

Under the low socioeconomic category, candidates must have attended a decile one to three secondary school during Years 11, 12 and 13. Parental income is not considered.

JOHN KIRK-ANDERSON/STUFF

Some of Jordan Tewhaiti-Smith's relatives - including his dad - are Mongrel Mob members. They were also his biggest supporters while he studied to become a doctor. (Video first published in December 2019)

In order to apply under the refugee sub-category, candidates for admission must have either been granted refugee status in New Zealand, or have parents/primary guardian(s) who have been granted refugee status.

Affirmative action is always controversial. Critics say it breeds resentment, stigmatises those students who avail themselves of the special categories and lowers the standards and prestige of an institution.

One of the objections is that it can give an unfair advantage to privileged students who actually have little in common with the minorities with whom they claim to have some genetic link. In other words, a Mori student from a relatively privileged home could be admitted over a European or Filipino student from a poorer home despite their better marks.

During his first presidential campaign, Barack Obama, said his two daughters who have had a pretty good deal should not benefit from affirmative action, particularly when they were competing with poor white students.

Some claim the system is open to abuseby wealthy students with a distant relative who is Mori orPasifika..

"These kids are attending private schools and are being allowed into medical school without achieving like the others must. It is not achieving the aims of helping Mori, says one parent.

Another parent asked if patients were better served by doctors who were"empathetic and more academic" regardless of ethnicity.

Professor Peter Crampton, whose parents immigrated from England to New Zealand when he was 12, and who worked as a GP in Porirua, near Wellington, is one of the main architects of the Mirror on Society policy at Otago University.

A former dean of the Otago Medical School and now professor of public health in Khatu Centre for Hauora Mori, he doesnt regard the issues around special entry into medical school as highly sensitive.

He says the purpose of the university is to produce a health workforce that meets the needs of society.

The-Southland-Times

Peter Crampton, aprofessor of public health, says medical schoolsselect students "for things we can't teach".

Doctors who belong to a rural or ethnic minority are more likely to serve those communities and provide the care that is not like the care provided by others.

He draws parallels to the dearth of female doctors in the medical workforce in previous decades.

It was thought men do that job very well and although we think of that as quaint and old fashioned, its not that long ago.

Mori doctors treating Mori patients could lead to better outcomes for multiple reasons, both interpersonal and because of the way systems are set up, he says.

He agrees no guarantee exists that students admitted under the sub-categories will go on to work in those areas and says its too early to tell whether the special entry scheme is helping to improve outcomes for Mori and Pacific patients.

We dont put on any of our students, any of them, any sort of moral weight to do a particular thing.

No affirmative system will have perfect rules and perfect compliance, he says. Defining a student's rural credentialssounded simple but coming up with a transparent and fair system was tricky.

He doesnt acceptthat students being admitted under the Mori or Pasifika sub-categories, who look European and have suffered none of the deprivations of low socioeconomic Mori or Pasifika, should not be allowed to take advantage of the easier route into medical school.

Nor does he agree that if Mori or Pasifika patients are to benefit from an affinity with the doctor, the doctor should look a bit like them.

If you are saying it would help if you look Mori I reject your framing entirely. Would it help if you looked gay?

We want the health workforce to broadly reflect the communities being served so that when you come into contact with the health force, whatever that touch point might be, there is some chance that system has been influenced by health professionals who share your world view, your ethnic affiliation or your gender and you meet a health professional who you might identify with and makes you feel at home within that system.

He finds the allegation that European-lookingstudents from well-off homes with slight Mori or Pacific ancestry are rorting the system hard to get a handle on.

You're conjuring up a phenomenon that encapsulates a world view that I would like to deconstruct.

He says Mori and Pacific students have a different socio-economic profile to general entry students although it is true the research in 2016 showed little movement in admitting more students from lower decile schools.

Any system of exclusion or inclusion is going to run into its difficulties at the margins with definitions.Its not perfect or watertight. Does that discredit the system,do we throw out a system because some people might not be eligible? The health workforce needs more Mori-Pacific students. We have not specified if they be rich or poor.

Although Mori and Pasifika students coming through the intermediate year pathway into Otago medical school were exceeding their proportion of the general population, the proportion of those groups in the medical workforce realistically will not catch up not in our lifetimes.

The marks required by general entry students was very high but people needed to remember why are we are doing this.

The high marks phenomenon is an artefact of selection processes. If I ask people, what do you like to see in your doctor? they say good communicator, honesty, compassion, altruism, along those lines. They never say we want them to have had straight As at school and through university.

We can't easily measure what we need to measure. Medicine does not need society's brightest students, it benefits from them but doesn't need them. That is an artefact of career aspirations occurring over decades.

We select people to meet certain characteristics we select them for things we can't teach. It is a demanding and difficult course and it needs people who are bright, capable and highly motivated. That is not the same as saying we need the top academic students. We don't have to have them.

Medical schools were sick of using marks.

He believed the UCAT thresholds were meaningful and helped exclude candidates who could be brilliant lab scientists but no good at face-to-face medicine.

So what would he say to Harry with his tremendous marks and who had his heart set on medicine?

Iunderstand their bitter disappointment and in my counselling I strongly encourage them to explore other options. So many young people base their sense of their identity and ambition on a particular academic pathway and feel quite devastated when that is not achieved. The world is full of amazing career opportunities for the academically capable."

Does he understand their resentment?

Thats where I come back to the policy and its intention. The policies are clear. To me personally and many colleagues in the university it's completely unacceptable that we have a health workforce devoid of Mori. We are rectifying that situation. The problem is that high marks have become the passport and because I've got high marks I should be a doctor.

*Notreal names.

Link:
Medical School: Who gets in and why - Stuff.co.nz

Read More...

Wilson Ighodalo: Addressing Substance Abuse as a Public Health Problem – THISDAY Newspapers

May 15th, 2020 7:45 pm

Founder,Drug Salvation Foundation,WilsonIghodalo, who alsodoubles as theNational Coordinator, NDLEA Celebrity Drug Free Club Nigeria,is also a United Nations Office on Drugs and Crime Master Trainer on Sensitisation on Drug and Drug Prevention, Treatment and Care. Known for his passion in addressing substance abuse, Ighodalo in this interview withChiemelie Ezeobi,stronglycanvassed for public health approach to tackle substance abuse in Nigeria

What is your take on the state of the health sector now?

At present the COVID-19 pandemic and how it is being addressed, should be a wakeup call to Nigeria. Public health approachis the single most important goal. Public health promotes and protects the health of people and the communities where they live, learn, work and play.

What is your take on substance abuse as a public health challenge?

There is need to reducesubstance abuse to protect the health, safety, and quality of life for all, especially children. Millions of Nigerians struggle with a drug or alcohol problem. Almost 95 per cent of people with substance use problems are considered unaware of their problem. Few of those who recognise their problem, many have made an unsuccessful effort to obtain treatment. These estimates highlight the importance of increasing prevention efforts and improving access to treatment for substance abuse and co-occurring disorders.

What are its impact on lives?

Substance abuse has a major impact on individuals, families, and communities. The effects of substance abuse are cumulative, significantly contributing to costly social, physical, mental, and public health problems. These problems include: teenage pregnancy, Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), other sexually transmitted diseases (STDs), domestic violence, child abuse, motor vehicle crashes, physical fights, crime, Homicide and suicide.

What was the impact of COVID-19 on children that are addicted to drugs?

Due to the lock down because of COVID-19, some children could no longer have access to drugs and the withdrawal syndromes are becoming more evident and some parents are just beginning to realise that their kids are using drugs. This has made a lot of them panic. I hope they seek for help to allay their fears.

So what is substance abuse?

Substance abuse refers to a set of related conditions associated with the consumption of mind- and behaviour-altering substances that have negative behavioral and health outcomes. Social attitudes and political and legal responses to the consumption of alcohol and illicit drugs make substance abuse one of the most complex public health issues. In addition to the considerable health implications, substance abuse has been a flash-point in the criminal justice system and a major focal point in discussions about social values: people argue over whether substance abuse is a disease with genetic and biological foundations or a matter of personal choice.

Advances in research have led to the development of evidence-based strategies to effectively address substance abuse. Improvements in brain-imaging technologies and the development of medications that assist in treatment have gradually shifted the research communitys perspective on substance abuse. There is now a deeper understanding of substance abuse as a disorder that develops in adolescence and, for some individuals, will develop into a chronic illness that will require lifelong monitoring and care.

Improved evaluation of community-level prevention has enhanced researchers understanding of environmental and social factors that contribute to the initiation and abuse of alcohol and illicit drugs, leading to a more sophisticated understanding of how to implement evidence-based strategies in specific social and cultural settings.

A stronger emphasis on evaluation has expanded evidence-based practices for drug and alcohol treatment. Improvements have focused on the development of better clinical interventions through research and increasing the skills and qualifications of treatment providers.

What are the emerging issues in substance abuse?

In recent years, the impact of substance and alcohol abuse has been notable across several areas, including the following: Adolescent abuse of prescription (Over The Counter OTC) drugs has continued to rise over the past five years. The recent survey found high rates of nonmedical use of the prescription pain relievers Tramadol and Codeine etc. It is believed that two factors have led to the increase in abuse. First, the availability of prescription drugs is increasing from many sources, including the family medicine cabinet, the Internet, and doctors. Second, many adolescents believe that prescription drugs are safer to take than street drugs.

In addition, as the federal governmentthrough Presidential Advisory Committee for the Elimination of Drug Abuse, (PACEDA) headed by Retired Brigadier-General Buba Marwa, should begin to implement health reform legislation, to focus attention on providing services for individuals with mental illness and substance use disorders, including new opportunities for access to and coverage of treatment and prevention services.

What is your foundation about?

The Drug Salvation Foundation is a non-government and Non-Profit

Organisation aimed at promoting the quality of public health in the society by leading efforts in the prevention, education, advocacy and care of

substance abuse disorders etc. The organisation is based in Lagos and have driven drug abuse interventions across the country, organising

trainings and prevention campaigns on substance abuse. It has organised various activities in a bid to raise awareness on drug abuse in the society. We have driven drug abuse interventions across the country, through quiz, debates, organising trainings, conferences, charity walk, courtesy visits, workshops, annual lectures and prevention campaigns on substance abuse.

We have reputable personality as board of trustees and founding fathers of this prestigious organisation in the person of Pastor ItuahIghodalo, who is the Chairman of The Drug Salvation Foundation. He is the Managing Partner at SIAO (a firm of CharteredAccountants and Management Consultants) and Senior Pastor Trinity House Church. We also have Otunba O.A. Lawal (Honorary Consul). He is at present the honorary Consul of Malta in Nigeria and the President of the Nigerian-Maltese Business Council.

Putting it in context, we are reaching out through advocacy campaign that seeks to address the current negative perception about people with drug related issues, by promoting evidence based approach which considers drug use as a public health, human rights and development agenda. It

rest on the fact that existing (criminalisation and discrimination) response has failed to effectively address the drug challenge in our society.

What we adopted in The Drug Salvation Foundation as best practice, we do in-house training for our personnel and clients. As part of the efforts to build capacities of staff and associates for optimum performance. All humans are born geniuses. The onus is on all of us to discover, nurture and develop it for the betterment of the society. The need therefore for training and retraining for an enhanced performance cannot be over emphasised.

What drives you in pushing issues against drug abuse in Nigeria?

Drug abuse in Nigeria is a major cause for concern, especially since children as young as eleven years old, are abusing drugs. That informed part of my passion to champion the cause and children are the future of tomorrow, focusing on prevention and promotion of healthy lifestyle against substance abuse now became my ways of touching lives. I found The Drug Salvation Foundation as a platform to share information and ideasabout the problem of substance abuse. This include sharing ideas on how to communicate the message of zero tolerance to drug use. It also highlights the fact that substance abuse interventions are aimed at saving lives, preserving familiesand building stronger communities.

A number of investigations show that Nigeria is experiencing a sharp increase in young people abusing substances like drugs and

alcohol. Many of the patients admitted to rehabilitation and treatment centres for substance abuse are children as young as 11 to 16 years old.

Drug and alcohol abuse at a young age is often the result of peer pressure, which starts at school. In addition, during the school holidays, children are often at home alone because their parents have to work. Children, especially teenagers, get bored and start hangingaround with the wrong group of people, bad influencers. They are then pressurised into trying new drugs, smoking or drinking alcohol, because they want to fit in.

Once children start using substances, they often become problematic drug users. To feed their addictions as they become involved in criminal activities as they try to get money to buy drugs. This can become a continuous cycle of conflict with the law. As part of our integrated approach towardspromoting a drug free society, our NGO also looks at ways to target schools and the inner city youths.

How many years have you championed this cause?

My sojourn started as a media consultant to National Drug Law Enforcement Agency NDLEA in 2004. I am a member of Advertising Practitioners Council of Nigeria(APCON), thus Iam an advertising practitioner.

What are the major challenges you have battled in the course of your journey in fighting drug abuse?

Funding and society approach to drug users. Funding from Corporate organisations and High-net-worth individuals (HNWI). We are still hoping corporate bodies and individuals should fund drug abuse awareness campaign and funds improving thecapacity of civil society organisations, so that we can properly take the awareness campaign to schools, inner cities youth, communities and parents, so that parents and communities leaders can properly educate their walls and youths who are more vulnerable to drug abuse. There are so many benefits for corporate sponsorship, but the major one is a Cause Related Marketing for their brand, society will see the organisation as worthy company that contribute positively to the society, sincerely, it will raise their profit. Also it is time now, organisations see drug abuse as public health issues. Substance abuse constitutes socioeconomic and cultural threat in our society today. The time has come for corporate organisations to fund drug abuse awareness campaign, as there corporate social responsibility to the society. We can not all fold our hands and allow the society to decay.

Why public health-based approach?

The society should start seeing drug abuse problems as public health issues and it need public health centred approach. Stressing that drug abuse is not a personalchoice rather a public health issue,substance abuse is a call for a public health-based approach to addressing and discussing the importance of building awareness of substance

abuse as a public health problem. Public health is the science of preventing disease and injury and promoting and protecting the health of populations and communities.

What about punitivedrug laws in Nigeria?

As part of ongoing advocacy against abuse and stigimatisation, as CSOs working on drugs, we are also championingdialogue with stakeholders that brings together key state institutions in charge of theenforcement of the drug legislation, civil society activist, public health workers, human rights

activist, media, lawyers and more importantly the most affected population to change the narrative about drug policy in Nigeria.

Continued here:
Wilson Ighodalo: Addressing Substance Abuse as a Public Health Problem - THISDAY Newspapers

Read More...

Preventive Medicine | American Medical Association

May 15th, 2020 7:44 pm

A specialist in Preventive Medicine focuses on the health of individuals and defined populations in order to protect, promote, and maintain health and well-being, and to prevent disease, disability, and premature death. They may be a specialist in Public Health and General Preventive Medicine, Occupational Medicine, or Aerospace Medicine. The distinctive components of Preventive Medicine include:

Biostatistics and the application of biostatistical principles and methodology;

Epidemiology and its application to population-based medicine and research;

Health services management and administration including: developing, assessing, and assuring health policies; planning, implementing, directing, budgeting,and evaluating population health and disease management programs; and utilizing legislative and regulatory processes to enhance health;

Control of environmental factors that may adversely affect health;

Control and prevention of occupational factors that may adversely affect health safety;

Clinical preventive medicine activities, including measures to promote health and prevent the occurrence, progression, and disabling effects of disease andinjury; and

Assessment of social, cultural, and behavioral influences on health.

Specialty training required prior to certification: Three years

A preventive medicine physician may become board-certified in three specialties as defined by the American Board of Preventive Medicine.

Aerospace MedicineAerospace medicine focuses on the clinical care, research and operational support of the health, safety and performance of crew and passengers of air and space vehicles, together with the support personnel who assist operation of such vehicles. This population often works and lives in remote, isolated, extreme or enclosed environments under conditions of physical and psychological stress. Practitioners strive for an optimal human-machine match in occupational settings rich with environmental hazards and engineering countermeasures.

Occupational MedicineOccupational medicine focuses on the health of workers, including the ability to perform work; the physical, chemical, biological and social environments of the workplace; and the health outcomes of environmental exposures. Practitioners in this field address the promotion of health in the workplace, and the prevention and management of occupational and environmental injury, illness and disability.

Public Health and General Preventive MedicinePublic health and general preventive medicine focuses on promoting health, preventing disease, and managing the health of communities and defined populations. These practitioners combine population-based public health skills with knowledge of primary, secondary and tertiary prevention-oriented clinical practice in a wide variety of settings.

Career paths can include working in public health, occupational medicine, aerospace medicine, clinical medicine, academic medicine, managed care, research, informatics, policy development and global health. These positions are often located in local, state and federal health agencies, professional health organizations, educational institutions, nonprofit health organizations, public health departments, industry, and all levels of government.

Traditionally, many physicians entering the field of preventive medicine had completed training and worked in another clinical specialty, but found they lacked the necessary skills to manage and treat larger populations, a core component of preventive medicine. Today, residency training for preventive medicine includes a preliminary clinical year (PY1) and specialty-specific training (PY2 and PY3) in general preventive medicine, occupational medicine or aerospace medicine. The PY2 and PY3 year includes a graduate degree for a Master of Public Health (MPH), Master of Science (MS) or Master of Business Administration (MBA).

According to the 2012 Association of American Medical Colleges salary survey, the median compensation for an academic medicine position in preventive medicine ranges from $144,000 to $172,000 in early career to $232,000 to $250,000 in late career.

Original post:
Preventive Medicine | American Medical Association

Read More...

Scientists say the best treatment for COVID-19 may be a cocktail of medicines – The Boston Globe

May 15th, 2020 7:44 pm

Dr. Barry Bloom, a professor at the Harvard T.H. Chan School of Public Health, said hes optimistic that one or more medicines better than remdesivir the experimental Gilead Sciences drug cleared for emergency use" on May 1 will be available by the years end. But he expects the standard of care will probably evolve and ultimately rely on a combination of drugs that pass muster in clinical trials.

You dont need only one drug, said Bloom, a pioneer in global health who devoted much of his career to treating tuberculosis. What we learned with HIV is that no one drug works very well. But if you put three drugs together that are pretty good drugs, you can control the virus for life.

Bloom and other experts suspect that unlike people with HIV, COVID-19 patients would require only short-term treatment with a combination of medicines and recover faster if they got them soon after symptoms appear.

A study published last Friday in Lancet, the respected medical journal, bolsters that notion. It found that patients with mild to moderate COVID-19 at six public hospitals in Hong Kong and the University of Hong Kong seemed to improve more quickly if treated with a three-drug combo, compared with a group that received a two-drug treatment. The triple combination featured three antiviral drugs: one used for HIV, another for hepatitis C, and a third for multiple sclerosis.

The federal website ClinicalTrials.gov lists more than 1,400 clinical trials related to COVID-19 planned or started around the world. A number of them involve combinations of approved and experimental drugs, including remdesivir.

Massachusetts General Hospital, which participated in the global trial of 1,063 coronavirus patients that led to the emergency use of remdesivir, plans to participate in a follow-up study that combines that antiviral medicine with another drug. That second drug is sold under the brand name Olumiant by Eli Lilly and is used to treat rheumatoid arthritis.

Dr. Libby Hohmann, principal investigator of the remdesivir trial at Mass. General, said the Gilead drug had a real statistically significant effect, but as a lot of people are saying, its not a magic bullet or home run. Thats why it makes sense to try to combine it with something else, she said.

Patients who received remdesivir had a 31 percent faster recovery than those who got a placebo, according to the National Institute of Allergy and Infectious Diseases, which ran the trial at 68 sites worldwide. The median recovery time was 11 days for patients who received remdesivir compared with 15 days for those who got a placebo.

Most researchers predict it will take a vaccine to end the pandemic and dont expect one to be approved and deployed for 12 to 18 months, in the most optimistic scenario. As a result, researchers around the world are studying more than 200 experimental treatments to help sick patients recover, according to a tracker by the Milken Institute, a Santa Monica, Calif.-based think tank.

At least 15 drug companies based in Massachusetts or with an outpost in the state are studying possible treatments, as are local academic laboratories.

The firms include the Japanese drug giant Takeda Pharmaceutical, which is working with multiple partners on a drug made from the plasma of people who recovered from disease; Cambridge-based Alnylam Pharmaceuticals, which is collaborating with a San Francisco biotech on technology to silence the genes in the virus that causes COVID-19; and Sarepta Therapeutics, a Cambridge biotech collaborating with the Defense Department on an RNA-based treatment.

Akshay Vaishnaw, who heads research and development at Alnylam, said his company and Vir Biotechnology hope to begin testing an inhaled medicine in humans around the end of the year. The partners will first see how the drug performs by itself, he said, but it would hardly be surprising if researchers ended up studying it as part of a combination treatment.

Combinations allow multiple lines of attack on the pathogen, Vaishnaw said.

Ultimately, researchers say, the standard of care may encompass a cocktail of antiviral drugs that use multiple targets, or it may be several different types of medicines, such as antiviral medicines and anti-inflammatory therapies.

"Infections between a virus and a host cell are complicated processes that involve many different steps, said Dr. Joseph Loscalzo, head of the department of medicine at Brigham and Womens Hospital. That, coupled with the fact that these viruses can mutate quickly, would argue that combinations would help optimize the chance for a cure.

Loscalzo coauthored a recent study that ranked more than 80 approved drugs for their potential to work against COVID-19. The researchers used artificial intelligence and other tools to screen over 7,000 medications now used to treat other conditions.

The National Emerging Infectious Diseases Laboratories at Boston University is testing the roughly 80 drugs on cells from monkeys and humans infected with the coronavirus, and scientists there expect to have results soon.

Although combining drugs holds promise, it can also pose risks, Loscalzo said.

Now you have to look at not just the toxicities of each drug, but the drugs when used in combination, he said. The [clinical] trial duration would likely be about the same, but getting to the point where you could, in a safe way, begin the trial requires more homework beforehand.

Some scientists say they would prefer to repurpose a medicine that has been approved by the Food and Drug Administration for another disease rather than develop a new drug and test it in clinical trials, which can take years.

With all the drugs being studied, said Bloom, the public health expert from Harvard, its likely that data will emerge in the next couple of months about medicines that are better than remdesivir. But, he said, its premature to bet on any single drug or mix.

Like combination drugs marketed for HIV, he added, an effective cocktail might also become a medicine that doctors could prescribe as a preventative to patients who are at high risk for catching COVID-19. Gilead, which makes remdesivir, sells such a pre-exposure prophylaxis," or PrEP, to prevent HIV. The product, marketed as Truvada, combines two medications.

A drug that you could give to healthy people who would be exposed that would be a new and appealing preventative therapy," Bloom said.

Jonathan Saltzman can be reached at jonathan.saltzman@globe.com

Continued here:
Scientists say the best treatment for COVID-19 may be a cocktail of medicines - The Boston Globe

Read More...

Can Complementary and Alternative Medicine Help Fight Covid-19? – stopthefud

May 15th, 2020 7:44 pm

Rajgopal Noidamboor in this Madras Courier piece:

If you have cold, put some turmeric in hot millk, add some ground pepper, cardamom and honey, froth it and drink it. It will make your throat feel good. Alternately, you can make some hot pepper rasam, mix it with rice and slurp it. To get rid of that darn cold, you coulf also mix ginger, lemon and honey to hot water and drink it. These are age-old recipes passed down from generations. Most of us remember getting these lessons from our grandmother.

Today, turmeric mixed in milk is called Turmeric Latte and sold in fancy cafeterias. But why does turmeric work? Thats because it is the one ingredient which has curcumin natures antiviral, antiseptic, antibacterial, anti-inflammatory and antioxidant. Similarly, Ashwagandha(Withania somnifera)is a natural, preventative intervention.

In the fight against COVID-19, the Ministry of Healths Ayush has creted a task force to look into how preventative complementary and alternative medicine can help fight COVID-19.

We have commissioned an independent scholar to produee a report that looks into the science behind natural alternatives.

Todays storyby Rajgopal Noidamboor looks at the role of complementary and alternative medicine in fighting COVID-19.

Like Loading...

Related

This entry was posted on May 15, 2020 at 10:26 am and is filed under Discussion.You can follow any responses to this entry through the RSS 2.0 feed.You can leave a response, or trackback from your own site.

Excerpt from:
Can Complementary and Alternative Medicine Help Fight Covid-19? - stopthefud

Read More...

Adele’s Doctor Details Healthy Diet That The Singer Took To Help Her Lose Weight – Medical Daily

May 15th, 2020 7:44 pm

Earlier this month, 15-time Grammy winner and esteemed artist Adele wowed the world when she showed off her slimmed-down figure out of nowhere. Thankfully, her doctor shared the singers tips and tricks in order to achieve her type of weight loss in a successful and healthy way shortly after the reveal.

Adeles Doctor Reveals How Singer Lost Weight In A Healthy Way

Winning the esteemed Grammy award 15 times in her ongoing career, Adele is best known for writing songs and ballads that explore lost love, heartbreak and finding ones self after. Shes also known for her powerhouse voice, which only helps in taking her songs to new heights.

But it seems like she still has more surprises up her sleeve since the singer recently wowed everyone by unexpectedly posing a photo showing her slimmed-down figure earlier this month. Shortly afterwards, Dr. Dominique Fradin-Read, her own doctor, revealed just how the singer managed to lose all that weight. Fradin-Read is MD-board certified in preventative medicine and anti-aging medicine with a university degree in nutrition .

I start by telling my patients that when it comes to weight loss, diet and exercisealonewill not be enough in most cases. That is why many patients that come to us have tried to lose weight, they did lose somewhat but put everything back on and often even more.For a successful and sustainable weight loss, we need to look at the whole person and not just address the weight upfront, the physician said.

I combine all the tools and methods in our therapeutic arsenal, starting with the most natural approaches and lifestyle changes, vitamins/supplements, to recommending peptides, rebalancing hormones and finally prescribing medications as appropriately for each patient, she added, saying that after starting her process with the patients, she works toward more intensive treatment.

As for what to eat, Fradin-Read suggested a diet made up of nutrient-rich food as well as protein, good fats, good carbohydrates, dairy and a few wine glasses a week. Green veggies should also take around two-third of the plate. One-third should be for protein, while the remaining space should be for carbs. She also suggested following the well-known Mediterranean diet.

Obesity may occur because of genetics, family history, environment and medical conditions, among other reasons that affect body weight. Pixabay

Originally posted here:
Adele's Doctor Details Healthy Diet That The Singer Took To Help Her Lose Weight - Medical Daily

Read More...

Functional Remedies & Dr. Joel Kahn: "I Stopped Eating Animal Foods at Age 18 to Survive and Learned That I Felt Amazing on Plant-Based…

May 15th, 2020 7:44 pm

Functional Remedies

Hemp is one of the oldest cultivated plants in the world with remnants of hemp cloth found in Mesopotamia (currently Iraq and Iran) dating back to 8,000 BC. Though the US history of hemp use does not date back that far, the first recorded use of hemp in the colonies dates to the 17th century. However, until the 2018 Farm Bill was signed, hemp cultivation in America was prohibited for nearly a century. This complete overhaul of the law made it legal for farmers to once again grow, process, and sell hemp commercially and legalized nationwide use.

We spoke to Andrew Campbell, the CEO of Functional Remedies, about the companys perfection of its proprietary hemp plants, its unique control from farm to cultivation to finished products using vertical integration, and the nutritional benefits of the phytonutrients in,Synchronicity, its full-spectrum oil.

Functional Remedies newest Brand Ambassador, the plant-based cardiologist Dr. Joel Kahn, also described the integration of Holistic Cardiology into his practice, how he became the founder of a vegan restaurant, and his love of the benefits Functional Remedies offers his patients.

Please introduce Functional Remedies to our readers and describe its history and mission.Functional Remedies has been developing the genetics of our plant and hand-pressed infusion process of our oil for over two decades. We have made all this effort to deliver our customers the most efficacious hemp oil on the planet. Everything we have done and continue to do is with consumers at the center of all our thinking and actions. We have developed a new branding proposition, Synchronicity, and have introduced new products that speak directly to our customers and meet their needs throughout their days and nights. Our mission, or our why, is straight forward; we exist to help people by bringing them healing qualities of the hemp plant. Our how is by creating the most efficacious hemp oil on the planet, and our what are the various form factors (tinctures, capsules, etc.) that act as delivery mechanisms for our full-spectrum oil and all its healing properties.

Please explain to our readers how full-spectrum hemp oil can support and enhance their wellness.Our full-spectrum hemp oil works in concert with the endocannabinoid system (ECS) by enhancing its ability to function properly. The human body naturally makes cannabinoids, but unfortunately, at times, it doesnt make the amount the ESC requires, thats where our full-spectrum hemp oil comes into play; it replenishes the body of its cannabinoid deficiencies. The ESC works with all the other systems in the human body (immune, nervous, respiratory, sensory, cardiovascular, etc.) and helps them work more efficiently. So our full-spectrum hemp oil makes the ECS system work better, and the ESC system makes all your other systems work better- all of this leads to a healthier, more balanced human.

What are the benefits of Full-Spectrum Hemp Oil versus CBD? The easiest way to put it is, Would you rather have freshly squeezed orange juice or frozen concentrate? Our full-spectrum hemp oil is freshly squeezed orange juice. CBD is only one cannabinoid that the hemp plant offers; our oil offers over 100 cannabinoids, along with other nutrients: terpenes and flavonoids. Additionally, to get the CBD isolate, companies burn and mangle the plant. We use a gentle hand pressed method to slowly infuse our hemp oil into MCT oil that produces the most bioavailable product on the market.

Have you seen an increased interest in your hemp oil products since the outbreak of COVID-19? Yes, we have. Yesterday the National Institute of Health (NIH), an organization we have been working with for years, asked us to participate in a working group regarding Covid-19. This will entail a series of calls with scientists discussing ideas and findings around this topic.

Functional Remedies is the only hemp company to receive three Good Manufacturing Practice (GMP) certifications. Please describe what this achievement means. It demonstrates to our customers the care we use throughout our growing and manufacturing processes to deliver the most efficacious and safest product to their bodies. We are all about quality and safety, and we spare no expense to ensure these two points. Additionally, we have an NSF certification and are well down the path in obtaining our ISO 9001 certification (the highest international standard involving the manufacturing of the forms we sell).

You recently announced your partnership with Dr. Joel Kahn as the companys new Brand Ambassador. How did this relationship develop? We are thrilled to have Dr. Kahn as part of the Functional Remedies family and team. We met Dr. Kahn a few years back, and he was gracious enough to try our products, and he noticed the difference with his patients immediately. Partnering with Dr. Kahn is another example of how Functional Remedies demonstrates its laser focus on quality, purity, and potency. Dr. Kahn only associates with first-class organizations, and we are honored and grateful to have his vote of confidence.

Dr. Joel Kahn, Cardiologist & Brand Ambassador:

You describe yourself as a Holistic Cardiologist. Please explain to our readers how your treatment differs from a typical Cardiologist.The inside joke is that a holistic doctor sees patients with a whole list of questions and problems. But more formally, holistic is interchangeable with functional, integrative, or natural. It is a training in cardiology that is quite rare so far that focuses on the root causes of illness and the whole person. Traditional cardiology makes a diagnosis of high blood pressure. Holistic cardiology inquiries about diet, sleep, fitness, stress, toxins at home and work, allergies, food intolerances, trauma, genetics, and silent infections. By diving deeper into causes of disease, some people can receive a natural therapy that corrects the underlying issue and avoids a prescription drug for life or a procedure or surgery.

You are considered one of the worlds top cardiologists. Do you attribute that to your focus on using plant-based nutrition as preventative medicine?I had a heart murmur as an infant, a noise the doctor heard, and began seeing a pediatric cardiologist from my earliest days. It proved to be more of a scare to my parents than any serious issue, but it put me in contact with heart specialists all of my youth. I was fascinated by the smells, noises, technology, and concerns the medical team expressed. By age ten, if you asked me my career plans, I would answer cardiology. Another coincidence is that in my first week in undergraduate studies at the University of Michigan, the dormitory food was so miserable, but the salad bar was amazing. I stopped eating animal foods at age 18 to survive and learned that I felt amazing on plant-based foods. I merged the two events in my medical training and strived to be the best in class in traditional training but also to further my new interest in nutrition. The final piece to the puzzle was three weeks after I began my first position teaching and practicing aggressive cardiology, a major research study was published showing that plant-based diets could reverse heart disease. I looked to the left and saw balloons and stents that I was using to reverse blockages, and I looked right at my fork and spoon being used only on plant meals, and I merged the two to practice what I called Interpreventional cardiology. I might need to put in a stent, but you were also going to get a lecture on nutrition, prevention, and plant-based recipes. It has been a wonderful combination.

What interested you in becoming the Brand Ambassador for Functional Remedies?I have strict criteria for sharing my name and energies with a project. Is there strong science? Are there high standards of quality? Are there passionate people? Can this help people? When I visited Functional Remedies and met the team, I saw how the product was made with love and vertical integration, how the quality and certifications were of the highest standards and heard the testimonials of people that worked for the company and many of my patients, I was hooked. I have a passion for helping people improve their lives with safe and natural approaches. Functional Remedies is simply the best in class, and I am so proud to be on board.

What motivated you to open your Detroit-based GreenSpace & Go plant-based eatery?I was lecturing all over the USA about the benefits of a plant diet for decades, but when I got back to Detroit, the choices of going out for a healthy meal consistent with my lectures were very limited. My son Daniel had restaurant experience and an MBA, and we sat down to consider a variety of food-related business plans and franchises. Ultimately, we laid out a plan to open a high-quality plant-based cafe to dine in or carry out. We strived to teach our guests the pleasures of fresh foods, prepared to order, and emphasizing quality, taste, and health. The response has been strong and joyful, and we have a lab to change options and lives by opening minds and mouths.

Your goal is to prevent all future heart attacks. If you can accomplish the task, what would be your next dream job?I am living my dream job. I am over 60 years old but jump out of bed every day excited to take on the challenges.If I could prevent all heart attacks, I would focus on aging. Aging is considered a natural process and not a disease. Yet all the common diseases that rob us of joy and health, like cancer and heart disease, are much more common as we age. We are learning the basic mechanisms of aging and developing ways to intervene to avoid the chronic deterioration that may rob us of our dignity in our later years. Imagine feeling good and energetic at 70, 80, or 90 years old! It can be a reality, and I am excited to be part of it. Using the highest quality natural products like Functional Remedies is part of that process. Farm, not Pharma is the answer, and being part of this team is a dream come true.

Related

Visit link:
Functional Remedies & Dr. Joel Kahn: "I Stopped Eating Animal Foods at Age 18 to Survive and Learned That I Felt Amazing on Plant-Based...

Read More...

The pandemic budget: moving New Zealand from critical care to long-term recovery – The Conversation AU

May 15th, 2020 7:44 pm

May 14s budget will surely be remembered as the pandemic budget. It might seem like the worst possible timing economic uncertainty rages, Treasury has had to abandon its usual economic forecasts, and the pandemics viral economic spread is far from over.

On the contrary, this may be very good budget timing. With the governments swift lockdown and border actions, we all hope coronavirus will soon be eliminated in New Zealand. The government also rightly took immediate action to support an economy forced into hibernation.

So now the budget arrives just as we are ready to move into phase two of recovery when government spending and tax policies need to change from preventative medicine to patient care.

So what budget action is needed? Despite some clamouring for a new pandenomics to guide policy, there is nothing different in principle about the post-elimination recession about to hit New Zealand, even if it turns out to be bigger than the unprecedented recession caused by the 2008 global financial crisis (GFC).

Negative economic shocks can be supply-driven, demand-driven or both. Each requires different policy responses.

The current crisis started as a (self-imposed) supply shock: firms had no choice but to scale back output while their costs persisted. This is why the governments supply-side wage subsidies and small business support were the right call (even if reasonable people can argue over their size and detail).

Read more: The ghosts of budgets past haunt New Zealand's shot at economic recovery

But as firms come out of hibernation, widespread wage subsidies should be mostly withdrawn. The government cannot possibly provide current levels of wage support for the next one to two years of economic fallout. Nor would it be desirable, as the economy adjusts to a longer recessionary phase. Keeping unsustainable businesses going through this would only undermine the needed adjustments.

Looking ahead, weak demand is more likely as unemployment rises, some businesses fail during this second phase and real wages fall. That is why this budgets timing is helpful. It is time to pivot away from sensible but unsustainable supply-side support, to combating the expected demand contraction and its consequences.

This doesnt depend on Treasury forecasts. We already know that output has dropped massively, with more to come. So preparation for stimulating fiscal policy such as expanding some government spending programmes (though much of this will happen automatically as tax revenues fall and welfare spending rises). Looser monetary policies should help, with the central bank injecting more liquidity into the economy.

This years pandemic budget should, however, look to redirect spending towards immediate support for those businesses and households that will now suffer most. Since total spending will inevitably rise, cutting back longer term and low impact projects needs to form part of this.

A good place to start would be the Provincial Growth Fund, the result of little more than expensive political horsetrading among the governments coalition partners. But somehow I doubt this option is what finance minister Grant Robertson meant last week when he signalled that certain pre-COVID-19 budget priorities will be put on ice.

In my view, two guiding principles should inform budget initiatives.

First, flexibility. Uncertainty around who will be worst affected, for how long and how severely, suggests that flexible support packages make more sense than widespread, predetermined handouts. Lets see where the economic recession bites, with packages in place to respond quickly, rather than trying to predict where the worst effects will be.

Direct government-to-business loans, for example, that can be applied for and granted subject to conditions, would ensure more targeted support. And with interest rates set close to government borrowing rates, they are a relatively low risk, low cost option. Those needing short term help and are able to recover will repay in due course. Those without a long term future would not be well served by delaying the inevitable at taxpayer expense.

Read more: Past pandemics show how coronavirus budgets can drive faster economic recovery

Secondly, plan a future debt trajectory. Much current debate surrounds the eventual taxpayer cost of massive public debt increases, perhaps rising from 20-50% of GDP. As with the post-WWII debt response, this will need to be brought back down, but more slowly than after the GFC, for example.

Public debt increases are global, and New Zealand will not look like a bad international credit risk for the foreseeable future. Plus, with interest rates almost certain to remain low for years, the governments debt servicing costs have never looked better. Nevertheless, a credible plan towards lower debt is essential if we are to be well prepared for the next crisis as we were for this one.

Some are suggesting this years budget initiatives will be pivotal for the economy. Maybe. Mostly, budgets are like yesterdays news. Who remembers the 2019 budget beyond the slogans? It was the hacked budget (which wasnt actually hacked, but prematurely revealed due to Treasury slip-ups). Or the Well-being Budget (the official title that was little more than political spin with a smiley cover photo; what were Bill Englishs social investment budgets about if not well-being?).

So, good luck Mr Robertson we hope your pandemic budget (or recovery budget as you are calling it) delivers more than a catchy strapline.

Read more:
The pandemic budget: moving New Zealand from critical care to long-term recovery - The Conversation AU

Read More...

P.E.I.’s chief public health officer inspired by B.C. counterpart – The Guardian

May 15th, 2020 7:44 pm

Chief public health officer Dr. Heather Morrison draws inspiration from her British Columbia counterpart, who is also a fellow Prince Edward Islander.

Dr. Bonnie Henry has inspired me certainly as a public health leader, Morrison told The Guardian in a recent telephone interview.

She is a friend and a colleague that I reach out to regularly. She has had such a steady, calm way of leading.

Henry, like Morrison, has received ongoing praise for demonstrating strength and compassion in the face of COVID-19. Henry has even reportedly been nominated for the Order of Canada in recognition of her leadership during the global pandemic.

The accolades being heaped on Henry come as no surprise to Morrison.

She is a great public health leader and role model, says Morrison.

She has had that ability to care and is able to have such a critical thinking about public health and population risk and to be able to communicate that, which is really something special.

Morrison's first working relationship with Henry was when Henry was working as interim provincial executive director of the B.C. Centre of Disease Control from December 2013 to August 2014 and Morrison was more than a handful of years into her current role.

The pair, of course, have had regular interaction during the pandemic.

Shes a pleasure to work with, says Morrison.

She will often say something referencing P.E.I. In the past we have had face-to-face meetings, and I always looked forward to seeing her then.

Henry, who grew up in Charlottetown, maintains a strong connection to Prince Edward Island.

Her parents live just a couple of blocks away from Morrisons home, and Henry's sister, niece and nephew live in the capital city.

Henry, unlike Morrison, has made a career away from P.E.I.

In 2000, Henry worked with the World Health Organization and UNICEF on a polio eradication program in Pakistan. The following year she went to Uganda to help combat an Ebola outbreak.

Morrison says her feet have been firmly planted on native soil since she was appointed chief public health officer for P.E.I. in 2007. She has never considered working elsewhere since the prestigious appointment.

Morrison makes a point to mention, whenever she can, that Henry, who was appointed as B.C.s provincial health officer Feb. 1, 2018, is a native of P.E.I.

RELATED:

Visit link:
P.E.I.'s chief public health officer inspired by B.C. counterpart - The Guardian

Read More...

Why Covid-19 will spark a wave of medical innovation – Telegraph.co.uk

May 15th, 2020 7:44 pm

New ways of working will boost medical innovation and benefit companies, shareholders, and the wider population

There are three things we know always happen in a crisis. Poor leaders get found out, as voters in the United States may already have already started to realise. The initial response is always completely hopeless, as we have discovered once again in Britain. And finally, and most importantly, whether it a war, a natural disaster, or an epidemic, eventually it sparks a wave of innovation because in the end human ingenuity always rises to a challenge.

The Covid-19 crisis is, at the risk of stating the obvious, the worst medical crisis we have witnessed in a century. But here is a bet, and one that matters to investors: it will also spark a much-needed wave of medical innovation. The last decade has been terrible for the pharmaceuticals and life sciences industry, with slowing innovation, defensive mergers, and dismal returns for shareholders.

However, that could be about to change because new ways of working will be discovered, regulations will be re-invented for a new era, and spending on healthcare will be increased. The companies that come up with treatments will be the big winners but the whole industry will start to flourish once again.

Over the next few months, every developed country will work its way through different strategies, from partial lockdowns to social distancing to herd immunity, to cope with Covid-19. But it remains the case that the only real solution will be scientific. Until we have a vaccine, or an effective drug treatment, the virus will justcome back again and again. There is no other way of beating it. One way or another, technology will have to rescue us.

The pharmaceuticals industry, although it wouldnt want it to happen this way, could use a boost. Its giants have all struggled over the past decade, and while the biotech start-ups may have raised a lot of money, very few of them have managed to live up to the hype. Just take a look at the figures.

Link:
Why Covid-19 will spark a wave of medical innovation - Telegraph.co.uk

Read More...

The Spotlight Series: coronary heart disease – Health and Happiness – Castanet.net

May 15th, 2020 7:44 pm

Photo: Contributed

The Spotlight Series is a series of articles looking at common, and preventable, diseases. I explain the science behind the condition, how to spot early signs and what you can do to prevent it.

The science

Coronary heart disease (also known as cardiovascular disease, or ischaemic heart disease) is one of the leading causes of death in Canada. It is also relatively preventable, by making small lifestyle adjustments.

Coronary heart disease is caused by a build-up of atheromas along the lining of the arteries around the heart (coronary arteries). Atheromas are deposits, made up largely of fat and cholesterol. This build up in the walls of the arteries makes the arteries narrower, which is called atherosclerosis.

This narrowing of the arteries means that the heart receives less blood. This can cause a variety of problems, the most common of which is angina. Angina is chest pain, that is brought on when the heart isnt getting enough blood. This can be because of physical activity or stressful situations, where the heart is beating faster and therefore requires more blood.

Another form of coronary heart disease is a myocardial infarction, or heart attack. This occurs when the arteries become completely blocked, meaning the heart isnt receiving any blood.

Heart failure can also be a consequence of coronary disease, as the heart becomes too weak to pump blood properly around the body. This can happen either suddenly or gradually.

Signs and symptoms

Angina causes chest pain that is typically associated with a heaviness, tightness or uncomfortable sensation, that may spread to the jaw, neck, arms or back. Angina is often triggered by exercise, and will pass quickly when you rest or use a nitrate spray.

If the pain doesnt go away when you rest, or if the pain is particularly severe, it may be a heart attack. People also experience symptoms like nausea, sweating, feeling faint or short of breath. If you experience these symptoms, call 911 immediately, as this is a life-threatening emergency.

Heart failure can happen gradually or suddenly, and usually presents with shortness of breath. This is due to a build up of fluid in the lungs because the heart cant effectively pump fluid around the body.

How to prevent heart disease

Luckily, you can reduce your risk of getting coronary heart disease easily by keeping your blood pressure and cholesterol levels in the normal range.

Eating a cardio-protective diet is the best place to start. Here are the key aspects of the cardio-protective diet:

The heart is a muscle like any other, and so its important to treat it as such. Giving it regular exercise is the best way to keep it healthy and prevent the onset of disease. Regular exercise keeps your circulatory system efficient, reduces your cholesterol, and keeps your blood pressure at a healthy level.

As well as eating well and exercising to protect your heart, giving up smoking is a hugely important part of preventing disease. Smoking is a major risk factor for coronary heart disease, as it causes the blood to be more sticky, and likely to atherosclerose.

Good news: drinking alcohol (albeit in small doses, and in low sugar forms) is actually a positive thing for heart health. Enjoy a glass of this regions awesome wine once or twice a week, and know that its on doctors orders! However, any alcohol in excess is not good, and binge drinking increases the risk of a heart attack. Be sensible.

Take home message

You guessed it its my motto! Eat well, exercise, and be aware of the signs and symptoms. If you believe you may be suffering from heart disease, speak to your family doctor. Even if you have heart disease, it is possible to reverse some of the damage to your arteries. Get in touch if you have any questions, or want to discuss this topic more.

Read the original here:
The Spotlight Series: coronary heart disease - Health and Happiness - Castanet.net

Read More...

Cuba lauded for one of the best health systems in the world. – stopthefud

May 15th, 2020 7:44 pm

By Shannon Ebrahim is Independent

It is no small feat that Cuba, impoverished for 60 years due to the US economic embargo, has one of the best health systems in the world, with more impressive health indicators than those of the US and many other developed countries. Cubas success is largely due to its unrelenting commitment to prevention and community oriented primary health care.

Cuba has one of the highest ratios of doctors in the world, with 8.2 doctors per thousand people, three times the rate in the US, which has 2.6 doctors per thousand people. South Korea has 2.4 doctors per thousand people, while Italy has 4.1. Cubas mortality rate is equally as impressive with a rate of 4 per 1,000 births, which is lower than that in the US, despite all its resources.

Cuba struggles with shortages of medicine in its pharmacies as a result of the US sanctions regime, but it has found ways to continue improving its universal healthcare for the Cuban population. Cuba spends an impressive 23% of its national budget on healthcare and 30% on education, comprising a total of 53% on education and health, compared to the US which spends 28% on health and education.

It is a shocking double standard that US companies are not allowed to export essential life saving medicine to a critically ill Cuban child if they are the child of a member of the Cuban Communist party. There are medications in the US for particular diseases that cannot be bought in Cuba. US regulations stipulate that US drug companies must certify the end-user if they want to sell medicine to Cubans. The end user cannot be a member of the Communist Party, according to the Helms-Burton Act, which was signed into law by former President Bill Clinton. Most US drug companies find such certification impractical and therefore refuse to export to Cuba.

Cuba has risen above these monumental challenges in acquiring medicine for its people, and these hurdles have actually spurred innovation and medical scientific research in the island nation, with amazing results. Cuba has made huge strides in biotech innovations, and specialises in antiviral drugs such as Interferon Alpha 2B, which is being used to combat Covid-19 in both Cuba and China. Cuba supplies Interferon in its public health system as a preventative measure to elevate the immune system. It is also used in the early stages of infection with Covid-19, whereby it is administered via nebulisation so that it reaches the lungs, and has shown to have a positive impact. It is also administered to positive Covid-19 patients in a critical state through Intramuscular injection. Interferon is now being produced with Cuban technology in Jilin in China at a joint venture facility.

Cubas state owned pharmaceutical industry has been prioritising the production of Covid-19 treatments and therapies, and has 21 other products being used to fight the virus such as antivirals, antiarrhythmics, and antibiotics. Cuba is also using Biomodulin T for recurring respiratory infections in older adults to increase a patients defences.

Cubas successful health system has been an example for the rest of the world. Cuba has the worlds largest medical schools the Havana Latin American School of Medicine which provides free education to 35,000 doctors from 138 countries since 1999. Scholarships to the medical school include full tuition, textbooks, accommodation, meals, and a stipend. Graduates are encouraged to practice on the frontlines in low income and medically underserved communities.

Cuba is committed to producing revolutionary doctors prepared to put their lives on the line both at home and abroad to save lives. Today Cuba has 50,000 doctors working in 61 countries at any one time, which is a feat not even the most developed countries can rival. It is truly remarkable that a tiny island nation which has endured suffocating economic sanctions imposed by the US for over 60 years can have accomplished so much for the betterment of humankind.

Like Loading...

Related

Excerpt from:
Cuba lauded for one of the best health systems in the world. - stopthefud

Read More...

Page 556«..1020..555556557558..570580..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick